Search

Author/Creator Weber, Michael A

2. Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Issue 10085 (3rd June 2017)

Authors:
Böhm, Michael; Schumacher, Helmut; Teo, Koon K; Lonn, Eva M; Mahfoud, Felix; Mann, Johannes F E; Mancia, Giuseppe; Redon, Josep; Schmieder, Roland E; Sliwa, Karen; Weber, Michael A; Williams, Bryan; Yusuf, Salim
Journal:
Lancet
Issue:
Volume 389:Issue 10085(2017)
Page Start:
2226
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Ambulatory heart rate reduction after catheter-based renal denervation in hypertensive patients not receiving anti-hypertensive medications: data from SPYRAL HTN-OFF MED, a randomized, sham-controlled, proof-of-concept trial. (4th January 2019)

Authors:
Böhm, Michael; Mahfoud, Felix; Townsend, Raymond R; Kandzari, David E; Pocock, Stuart; Ukena, Christian; Weber, Michael A; Hoshide, Satoshi; Patel, Manesh; Tyson, Crystal C; Weil, Joachim; Agdirlioglu, Tolga; Fahy, Martin; Kario, Kazuomo
Journal:
European heart journal
Issue:
Volume 40:Number 9(2019)
Page Start:
743
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Blood pressure and glycaemic effects of dapagliflozin versus placebo in patients with type 2 diabetes on combination antihypertensive therapy: a randomised, double-blind, placebo-controlled, phase 3 study. Issue 3 (March 2016)

Authors:
Weber, Michael A; Mansfield, Traci A; Cain, Valerie A; Iqbal, Nayyar; Parikh, Shamik; Ptaszynska, Agata
Journal:
Lancet
Issue:
Volume 4:Issue 3(2016)
Page Start:
211
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Blood pressure variability and risk of cardiovascular events and death in patients with hypertension and different baseline risks. (20th January 2018)

Authors:
Mehlum, Maria H; Liestøl, Knut; Kjeldsen, Sverre E; Julius, Stevo; Hua, Tsushung A; Rothwell, Peter M; Mancia, Giuseppe; Parati, Gianfranco; Weber, Michael A; Berge, Eivind
Journal:
European heart journal
Issue:
Volume 39:Number 24(2018)
Page Start:
2243
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Cardiovascular Benefits of Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade in Patients Achieving Tight Blood Pressure Control and With Resistant Hypertension. (20th November 2020)

Authors:
Brook, Robert D; Kaciroti, Niko; Bakris, George; Dahlöf, Björn; Pitt, Bertrtam; Velazquez, Eric; Weber, Michael A; Jamerson, Kenneth A
Journal:
American journal of hypertension
Issue:
Volume 34:Number 5(2021)
Page Start:
531
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk. (28th March 2019)

Authors:
Böhm, Michael; Schumacher, Helmut; Teo, Koon K; Lonn, Eva M; Mahfoud, Felix; Mann, Johannes F E; Mancia, Giuseppe; Redon, Josep; Schmieder, Roland E; Marx, Nikolaus; Sliwa, Karen; Weber, Michael A; Williams, Bryan; Yusuf, Salim
Journal:
European heart journal
Issue:
Volume 40:Number 25(2019)
Page Start:
2032
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Issue 10108 (11th November 2017)

Authors:
Townsend, Raymond R; Mahfoud, Felix; Kandzari, David E; Kario, Kazuomi; Pocock, Stuart; Weber, Michael A; Ewen, Sebastian; Tsioufis, Konstantinos; Tousoulis, Dimitrios; Sharp, Andrew S P; Watkinson, Anthony F; Schmieder, Roland E; Schmid, Axel; Choi, James W; East, Cara; Walton, Anthony; Hopper, ...
Journal:
Lancet
Issue:
Volume 390:Issue 10108(2017)
Page Start:
2160
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial. Issue 10367 (3rd December 2022)

Authors:
Schlaich, Markus P; Bellet, Marc; Weber, Michael A; Danaietash, Parisa; Bakris, George L; Flack, John M; Dreier, Roland F; Sassi-Sayadi, Mouna; Haskell, Lloyd P; Narkiewicz, Krzysztof; Wang, Ji-Guang; Reid, Christopher; Schlaich, Markus; Katz, Ivor; Ajani, Andrew; Biswas, Sinjini; Esler, Murray; ...
Journal:
Lancet
Issue:
Volume 400:Issue 10367(2022)
Page Start:
1927
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗